Hiroko Shibata
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Protein purification and stability 17
- RNA Interference and Gene Delivery 7
- Glycosylation and Glycoproteins Research 6
-
- Monoclonal and Polyclonal Antibodies Research 22
- Co-authors
- Masato Tanaka (1 shared paper)Yasuo Tsutsumi (29 shared papers)Shinsaku Nakagawa (24 shared papers)Yohei Mukai (22 shared papers)Haruhiko Kamada (22 shared papers)Shin‐ichi Tsunoda (18 shared papers)Tadanori Mayumi (16 shared papers)Takayuki Okamoto (13 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (10 papers)Journal of Pharmaceutical Sciences (7 papers)Biochemical and Biophysical Research Communications (6 papers)International Journal of Pharmaceutics (3 papers)Chemical and Pharmaceutical Bulletin (3 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Hiroko Shibata
80 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Biomaterials 245
- Pharmaceutical Science 113
- Immunology 258
- Molecular Biology 738
- Radiology, Nuclear Medicine and Imaging 247
Countries citing papers authored by Hiroko Shibata
This map shows the geographic impact of Hiroko Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Shibata more than expected).
Fields of papers citing papers by Hiroko Shibata
This network shows the impact of papers produced by Hiroko Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Shibata. The network helps show where Hiroko Shibata may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Shibata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 164 | |
| 2 | 1985 | 157 | |
| 3 | 2004 | 62 | |
| 4 | 2008 | 58 | |
| 5 | 2003 | 57 | |
| 6 | 2018 | 53 | |
| 7 | 2004 | 46 | |
| 8 | 2008 | 46 | |
| 9 | 2009 | 45 | |
| 10 | 2004 | 45 | |
| 11 | 2007 | 39 | |
| 12 | 2004 | 37 | |
| 13 | 2007 | 34 | |
| 14 | 2004 | 33 | |
| 15 | 2014 | 30 | |
| 16 | 2013 | 28 | |
| 17 | 2016 | 28 | |
| 18 | 1980 | 28 | |
| 19 | 2016 | 27 | |
| 20 | 2017 | 27 |
About Hiroko Shibata
Hiroko Shibata is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Biomedical Engineering and Pharmacology, having authored 85 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), Protein purification and stability (17 papers), Biosimilars and Bioanalytical Methods (9 papers), RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Glycosylation and Glycoproteins Research (6 papers), Bacteriophages and microbial interactions (5 papers) and Pharmacy and Medical Practices (5 papers). The work is most often cited by research in Biomaterials (245 citations), Pharmaceutical Science (113 citations), Immunology (258 citations), Molecular Biology (738 citations) and Radiology, Nuclear Medicine and Imaging (247 citations). Hiroko Shibata has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Masato Tanaka, Yasuo Tsutsumi, Shinsaku Nakagawa, Yohei Mukai, Haruhiko Kamada, Shin‐ichi Tsunoda, Tadanori Mayumi, Takayuki Okamoto, Yasuo Yoshioka and Yukihiro Goda. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Pharmaceutical Sciences, Biochemical and Biophysical Research Communications, International Journal of Pharmaceutics and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.